bufogenin has been researched along with marinobufagenin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Danchuk, S; Ianosi-Irimie, M; Kamano, Y; Nogawa, T; Pettit, GR; Puschett, JB; Rabon, E; Vu, H; Wiese, T | 1 |
| Danchuk, S; Horvat, D; Puschett, JB; Sukhanov, S; Uddin, MN | 1 |
| Agunanne, E; Puschett, JB; Uddin, MN | 2 |
| Agunanne, EE; Horvat, D; Puschett, JB; Uddin, MN | 2 |
| Agunanne, E; Demorrow, S; Horvat, D; Puschett, JB; Uddin, MN | 1 |
| Puschett, JB | 1 |
| Deng, S; Ge, GB; Hou, J; Hu, LH; Huo, XK; Ma, XC; Ning, J; Wang, C; Wu, JJ; Yang, L; Yu, ZL | 1 |
| Abbas, MMK; Barrios, R; Chen, Q; Jiang, W; Moorthy, B; Patel, B; Puschett, JB | 1 |
| Aziz, MA; Bakar, NS; Basah, NK; Hassan, MJM; Singh, HJ | 1 |
2 review(s) available for bufogenin and marinobufagenin
| Article | Year |
|---|---|
Emerging role of the bufadienolides in cardiovascular and kidney diseases.
Topics: Animals; Blood Volume; Bufanolides; Capillary Permeability; Cardiotonic Agents; Cytokines; Female; Heart Diseases; Humans; Hypertension; Molecular Structure; Pre-Eclampsia; Pregnancy; Renal Insufficiency, Chronic; Vascular Resistance; Vasoconstrictor Agents; Young Adult | 2010 |
Marinobufagenin predicts and resibufogenin prevents preeclampsia: a review of the evidence.
Topics: Animals; Blood Pressure; Bufanolides; Capillary Permeability; Cardenolides; Clinical Trials as Topic; Disease Models, Animal; Endothelium, Vascular; Female; Hematocrit; Humans; Pre-Eclampsia; Pregnancy; Saponins; Treatment Outcome | 2012 |
9 other study(ies) available for bufogenin and marinobufagenin
| Article | Year |
|---|---|
Resibufogenin corrects hypertension in a rat model of human preeclampsia.
Topics: Animals; Blood Pressure; Bufanolides; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Hypertension; Isoenzymes; Molecular Structure; Ouabain; Pre-Eclampsia; Pregnancy; Rats; Sodium-Potassium-Exchanging ATPase | 2006 |
Effects of resibufogenin in experimental hypertension.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Bufanolides; Creatinine; Desoxycorticosterone; Disease Models, Animal; Hypertension, Renal; Male; Mineralocorticoids; Proteinuria; Rats; Rats, Inbred Strains; Sodium Chloride; Superoxides; Vasoconstrictor Agents | 2008 |
Marinobufagenin, resibufogenin and preeclampsia.
Topics: Animals; Bufanolides; Disease Models, Animal; Female; Fetal Growth Retardation; Humans; Mitogen-Activated Protein Kinase Kinases; Pre-Eclampsia; Pregnancy; Proteinuria; Rats; Sodium-Potassium-Exchanging ATPase | 2010 |
Contribution of angiogenic factors in a rat model of pre-eclampsia.
Topics: Analysis of Variance; Angiogenic Proteins; Animals; Blood Pressure; Bufanolides; Creatinine; Endoglin; Female; Gestational Age; Hematocrit; Intracellular Signaling Peptides and Proteins; Models, Animal; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Proteinuria; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2010 |
Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia.
Topics: Animals; Apoptosis; Blotting, Western; Bufanolides; Caspase 3; Caspase 8; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; Female; Humans; Male; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Trophoblasts; Vascular Endothelial Growth Factor Receptor-1; Vasoconstrictor Agents | 2011 |
Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia.
Topics: Animals; Bufanolides; Disease Models, Animal; Female; Oxidative Stress; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley | 2012 |
Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity.
Topics: Animals; Antineoplastic Agents; Bufanolides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dogs; Guinea Pigs; Humans; Hydroxylation; Kinetics; Liver; Macaca fascicularis; Male; Metabolic Detoxication, Phase I; Mice; Mice, Inbred ICR; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2015 |
Involvement of the Bufadienolides in the Detection and Therapy of the Acute Respiratory Distress Syndrome.
Topics: Acute Lung Injury; Animals; Biomarkers; Bufanolides; Case-Control Studies; Disease Models, Animal; Humans; Hyperoxia; Pulmonary Alveoli; Pulmonary Edema; Rats; Respiratory Distress Syndrome; Up-Regulation | 2017 |
Leptin-induced increase in blood pressure and markers of endothelial activation during pregnancy in Sprague Dawley rats is prevented by resibufogenin, a marinobufagenin antagonist.
Topics: Animals; Blood Pressure; Bufanolides; Endothelin-1; Endothelium, Vascular; Female; Intercellular Adhesion Molecule-1; Leptin; Pre-Eclampsia; Pregnancy; Proteinuria; Rats; Rats, Sprague-Dawley; Vascular Cell Adhesion Molecule-1 | 2020 |